MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Price to free cash flow
MiniMed Group, Inc. has no meaningful price to free cash flow: its trailing twelve-month free cash flow is negative. Over the past ten years it has ranged from 0.0× (November 2026) to 0.0× (November 2026) — the current reading is the highest in ten years.
Price to free cash flow, daily
Embed this chart
Annual newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| FY2026 | 0.0× | — |
| FY2025 | 0.0× | — |
| FY2024 | 0.0× | — |
Quarterly newest first
| Period | Price to free cash flow | Change |
|---|---|---|
| Jul 2026 | 0.0× | — |
| Jan 2026 | 0.0× | — |
| Jul 2025 | 0.0× | — |
| Jan 2025 | 0.0× | — |
Against its own ten years
Price to free cash flow against peers
| Company | Price to free cash flow |
|---|---|
| STVN Stevanato Group S.p.A. compare | n/m |
| PLSE Pulse Biosciences, Inc compare | n/m |
| MMED MiniMed Group, Inc. | n/m |
| NVST Envista Holdings Corporation compare | 16.4× |
| ICUI ICU Medical, Inc. compare | 21.2× |
| MMSI Merit Medical Systems, Inc. compare | 23.6× |
| BLCO Bausch + Lomb Corporation compare | 31.4× |
| TFX Teleflex Incorporated compare | 125× |
| ATRC AtriCure, Inc. compare | 129× |
| Medical Instruments & Supplies industry median | 23.5× |
| Healthcare sector median | 21.1× |
| Market median | 14.1× |
What Price to free cash flow is
Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.
Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement